ReviewNeurochemical research2026
ZBP1 at the Interface of Nucleic-Acid Stress and Inflammatory Cell Death After Intracerebral Hemorrhage: A Hypothesis-Driven Overview.
Review in Neurochemical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Intracerebral hemorrhage (ICH) creates a sterile perihematomal niche in which erythrocyte lysis, heme and iron toxicity, mitochondrial damage, blood-brain barrier disruption and innate immune activation converge. Which nucleic-acid sensors translate this biochemical stress into inflammatory cell death remains unresolved. Z-DNA-binding protein 1 (ZBP1) can recognize Z-conformation nucleic acids and couple ligand sensing to RIPK1, RIPK3, MLKL, caspase-8 and inflammasome-associated modules. We performed a targeted, evidence-graded narrative search, updated on 29 August 2026, to ask four questions: which components of the proposed pathway are established in ICH, which are transferable from other systems, which remain hypothetical, and what findings would falsify or validate the model? ICH studies demonstrate cytosolic mitochondrial DNA release and increasingly support cGAS-STING and AIM2 activation, while genetic and biochemical studies establish RIPK1-RIPK3-MLKL-dependent necroptotic signaling. However, Z-conformation ligands, ZBP1 ligand binding, ZBP1-containing complex assembly and ZBP1-dependent injury have not been demonstrated in ICH. The two ICH reports involving ZBP1 provide transcriptomic or intervention-associated observations rather than dependency evidence. Human and murine ZBP1 also differ in RIPK1/RIPK3 and RHIM requirements, limiting direct translation from mouse genetics. We therefore frame ZBP1 as a falsifiable candidate mechanism, not an established target, and define validation criteria based on cell-type-specific loss of function, ligand capture, complex formation, pathway epistasis, functional rescue and preservation of hematoma clearance.
Indexed as
Identifiers
42873377What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.